ArticleJTO clinical and research reports2026
Durvalumab Consolidation Treatment Following Concurrent Chemoradiotherapy in Limited-Stage SCLC: ADRIATIC China Subgroup Analysis.
Lixia Ma et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.